Shannon Herald
Psychiatric/Mental Health · Hazard, KYNPI 1114107307
Payments from drug & device makers
Across 144 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$455
- Otsuka America Pharmaceutical, Inc.$257
- AbbVie$252
- Axsome Therapeutics, Inc.$251
- Alkermes, Inc.$247
- Corcept Therapeutics$195
- plus $999 from 17 others
What the payments were for
- Food & beverage$2,656100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $455 |
| Otsuka America Pharmaceutical, Inc. | 13 | $257 |
| AbbVie | 13 | $252 |
| Axsome Therapeutics, Inc. | 12 | $251 |
| Alkermes, Inc. | 13 | $247 |
| Corcept Therapeutics | 10 | $195 |
| Lundbeck LLC | 11 | $169 |
| Sunovion Pharmaceuticals Inc. | 12 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $132 |
| Novo Nordisk | 6 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Amgen | 3 | $50 |
| Indivior Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Boehringer Ingelheim | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Novartis | 1 | $12 |
| Genentech USA, Inc. | 3 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$107
How this compares
$2,656 in reported general payments places this provider in the 75th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 84 | $238,547 |
| RexultiBrexpiprazole | 31 | $45,900 |
| VraylarCariprazine Hcl | 28 | $41,345 |
| Paliperidone ErPaliperidone | 37 | $10,456 |
| TrintellixVortioxetine Hydrobromide | 21 | $9,793 |
| Chlorpromazine Hcl | 18 | $8,000 |
| QuviviqDaridorexant Hcl | 15 | $7,300 |
| Lurasidone Hcl | 19 | $4,650 |
| Aripiprazole | 117 | $4,593 |
| Bupropion XlBupropion Hcl | 127 | $1,515 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 137 | $1,498 |
| Duloxetine Hcl | 113 | $1,348 |
| Buspirone Hcl | 211 | $1,307 |
| Quetiapine Fumarate | 112 | $1,287 |
| Clonazepam | 264 | $1,274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $455 | $238,54784 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $257 | $45,90031 claims |
| AbbVieVraylar | $252 | $41,34528 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $132 | $9,79321 claims |
| Lilly USA, LLCOlanzapine | $17 | $32733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Hazard
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
- Davika MattoxMorehead$79K
- Molly LutzCrestview Hills$71K
- Hope SmithHopkinsville$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.